http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20080085796-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_079a5b3eecbeb0e5fcc2e9b817b28c97 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-061 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 |
| filingDate | 2008-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_178480ded155205fee04204df18a9239 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c19f2d0987259675035b6fe276474834 |
| publicationDate | 2008-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20080085796-A |
| titleOfInvention | Spinorpin derivatives as effective and selective human Ρ2Χ3 receptor antagonists |
| abstract | The present invention relates to spinnor derivatives as effective and selective human P2X 3 receptor antagonists. More specifically, it relates to spinorphine derivatives as effective and selective human P2X 3 receptor antagonists selected from peptide AVVYPWT, peptide LAVYPWT, peptide LVAYPWT, peptide LVVAPWT and peptide cyclic LVVYPWT. The invention also RY gen crispus to Nord to characterize the channel blocking activity and a short recognition of the pin (Xenopus) I recombinant human P2X 3 7 gae alanine scanned RY Nord pin peptide derivative of the receptor expression in the cells of the P2X 3 receptor By measuring the electrophysiological evaluation of cleaved peptide analogs, cyclic peptides and retro-inverso peptides, a novel spinorphine derivative was developed. |
| priorityDate | 2008-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 105.